Chantal Lackey
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chantal Lackey.
Journal of Biomedical Materials Research | 2000
Allan S. Hoffman; Patrick S. Stayton; Volga Bulmus; Guohua Chen; Jingping Chen; Chuck Cheung; Ashutosh Chilkoti; Zhongli Ding; Liangchang Dong; Robin B. Fong; Chantal Lackey; Cynthia J. Long; Morikazu Miura; John E. Morris; Niren Murthy; Yoshikuni Nabeshima; Tae Gwan Park; O. W. Press; Tsuyoshi Shimoboji; Sara G. Shoemaker; Heung Joon Yang; Nobuo Monji; Robert C. Nowinski; Carole Ann Cole; John H. Priest; J. Milton Harris; Katsuhiko Nakamae; Takashi Nishino; Takashi Miyata
Over the past 18 years we have been deeply involved with the synthesis and applications of stimuli-responsive polymer systems, especially polymer-biomolecule conjugates. This article summarizes our work with one of these conjugate systems, specifically polymer-protein conjugates. We include conjugates prepared by random polymer conjugation to lysine amino groups, and also those prepared by site-specific conjugation of the polymer to specific amino acid sites that are genetically engineered into the known amino acid sequence of the protein. We describe the preparation and properties of thermally sensitive random conjugates to enzymes and several affinity recognition proteins. We have also prepared site-specific conjugates to streptavidin with temperature-sensitive polymers, pH-sensitive polymers, and light-sensitive polymers. The preparation of these conjugates and their many fascinating applications are reviewed in this article.
Journal of Controlled Release | 2000
Patrick S. Stayton; Allan S. Hoffman; Niren Murthy; Chantal Lackey; Charles Y. Cheung; Philip H. Tan; Lisa A. Klumb; Ashutosh Chilkoti; F.Scott Wilbur; Oliver W. Press
There are many protein and DNA based therapeutics under development in the biotechnology and pharmaceutical industries. Key delivery challenges remain before many of these biomolecular therapeutics reach the clinic. Two important barriers are the effective targeting of drugs to specific tissues and cells and the subsequent intracellular delivery to appropriate cellular compartments. In this review, we summarize protein engineering work aimed at improving the stability and refolding efficiency of antibody fragments used in targeting, and at constructing new streptavidin variants which may offer improved performance in pre-targeting delivery strategies. In addition, we review recent work with pH-responsive polymers that mimic the membrane disruptive properties of viruses and toxins. These polymers could serve as alternatives to fusogenic peptides in gene therapy formulations and to enhance the intracellular delivery of protein therapeutics that function in the cytoplasm.
Biotechnology and Bioprocess Engineering | 2001
Allan S. Hoffman; Patrick S. Stayton; Oliver W. Press; Niren Murthy; Chantal Lackey; Charles Y. Cheung; Fiona Black; Jean S. Campbell; Nelson Fausto; Themis R. Kyriakides; Paul Bornstein
One of the important characteristics of biological systems is their ability to change important properties in response to small environmental signals. The molecular mechanisms that biological molecules utilize to sense and respond provide interesting models for the development of “smart” polymeric biomaterials with biomimetic properties. An important example of this is the protein coat of viruses, which contains peptide units that facilitate the trafficking of the virus into the cell via endocytosis, then out of the endosome into the cytoplasm, and from there into the nucleus. We have designed a family of synthetic polymers whose compositions have been designed to mimic specific peptides on viral coats that facilitate endosomal escape. Our biomimetic polymers are responsive to the lowered pH within endosomes, leading to disruption of the endosomal membrane and release of important biomolecular drugs such as DNA, RNA, peptides and proteins to the cytoplasm before they are trafficked to lysosomes and degraded by lysosomal enzymes. In this article, we review our work on the design, synthesis and action of such smart, pH-sensitive polymers.
Bioconjugate Chemistry | 2002
Chantal Lackey; Oliver W. Press; Allan S. Hoffman; Patrick S. Stayton
Bioconjugate Chemistry | 1999
Chantal Lackey; Niren Murthy; Oliver W. Press; David A. Tirrell; Allan S. Hoffman; Patrick S. Stayton
Polymers for Advanced Technologies | 2002
Allan S. Hoffman; Patrick S. Stayton; Oliver W. Press; Niren Murthy; Chantal Lackey; Charles Y. Cheung; Fiona Black; Jean S. Campbell; Nelson Fausto; Themis R. Kyriakides; Paul Bornstein
Orthodontics & Craniofacial Research | 2005
P. S. Stayton; Mohammed E H El-Sayed; Niren Murthy; Volga Bulmus; Chantal Lackey; Charles Y. Cheung; Allan S. Hoffman
Proceedings of the IEEE | 2005
Patrick S. Stayton; Allan S. Hoffman; Mohamed El-Sayed; Samarth Kulkarni; Tsuyoshi Shimoboji; Niren Murthy; Volga Bulmus; Chantal Lackey
Journal of Biomedical Nanotechnology | 2007
A. S. Hoffman; P. S. Stayton; Mohamed El-Sayed; Niren Murthy; Volga Bulmus; Chantal Lackey; Charles Y. Cheung
Archive | 2002
Patrick S. Stayton; Allan S. Hoffman; Oliver W. Press; Niren Murthy; Chantal Lackey; Charles Y. Cheung; Tsuyoshi Shimoboji; Zhongli Ding; Fiona Black; Jean S. Campbell; Nelson Fausto; Themis R. Kyriakides; Paul Bornstein